Altered cytoskeleton organization in platelets from patients with MYH9-related disease

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 5, 2005, Pages 1026-1035

  Canobbio, I ^a   Noris, P ^a   Pecci, A ^a   Balduini, A ^a   Balduini, C L ^a   Torti, Mauro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cytoskeleton; MYH9 related disease; Myosin; Platelets

Indexed keywords

CYTOSKELETON PROTEIN; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN IIA; PROTEIN TYROSINE KINASE; GLYCOPROTEIN; MOLECULAR MOTOR; MYH9 PROTEIN, HUMAN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; CYTOSKELETON; GENE MUTATION; HUMAN; MEGAKARYOCYTE; MYH9 RELATED DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; ADOLESCENT; ADULT; CHEMISTRY; DIMERIZATION; DOMINANT GENE; FAMILY HEALTH; FEMALE; GENETIC POLYMORPHISM; GENETICS; IMMUNOBLOTTING; MALE; METABOLISM; MIDDLE AGED; MUTATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE DISORDER;

ADOLESCENT; ADULT; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; CYTOSKELETON; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FAMILY HEALTH; FEMALE; GENES, DOMINANT; GLYCOPROTEINS; GTP PHOSPHOHYDROLASES; HUMANS; IMMUNOBLOTTING; MALE; MEGAKARYOCYTES; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; NONMUSCLE MYOSIN TYPE IIA; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

EID: 23844448102     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01244.x     Document Type: Article

References (43)

1. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A. MYH9-related disease. May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 2003; 82: 203-15.
2. Geddis AE, Kaushansky K. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production. Curr Opin Pediatr 2004; 16: 15-22.
3. Kunishima S, Matsushita T, Kojima T, Amemiya N, Choi YM, Hosaka N, Inoue M, Jung Y, Mamiya S, Matsumoto K, Miyajima Y, Zhang G, Ruan C, Saito K, Song KS, Yoon HJ, Kamiya T, Saito H. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusion. J Hum Genet 2001; 46: 722-9.
4. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias. May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69: 1033-45.
5. Lusher JM, Schneider J, Mizukami I, Evans RK. The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood 1968; 32: 950-61.
6. Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium. Nat Genet 2000; 26: 103-5.
7. Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000; 26: 106-8.
8. Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, Nakamura Y, Okamura T, Amemiya N, Nakayama T, Kamiya T, Saito H. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 2001; 97: 1147-9.
9. Greinacher A, Nieuwenhuis HK, White JG. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut 1990; 61: 282-8.
10. Rocca B, Laghi F, Zini G, Maggiano N, Landolfi R. Fechtner syndrome: report of a third family and literature review. Br J Haematol 1993; 85: 423-6.
11. Arrondel C, Vodovar N, Knebelmann B, Grunfeld JP, Gubler MC, Antignac C, Heidet L. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002; 13: 65-74.
12. Seri M, Savino M, Bordo D, Cusano R, Rocca B, Meloni I, Di Bari F, Koivisto PA, Bolognesi M, Ghiggeri GM, Landolfi R, Balduini CL, Zelante L, Ravazzolo R, Renieri A, Savoia A. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet 2002; 110: 182-6.
13. Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta 2000; 1496: 3-22.
14. Franke JD, Dong F, Rickoll WL, Kelley MJ, Kiehart DP. Rod mutations associated with MFH9-related disorders disrupt non-muscle myosin-IIA assembly. Blood 2004; prepublished online August 31, DOI 10.1182.
15. Nagasaki A, de Hostos EL, Uyeda TQ. Genetic and morphological evidence for two parallel pathways of cell-cycle-coupled cytokinesis in Dictyostelium. J Cell Sci 2002; 115: 2241-51.
16. Mansfield PJ, Shayman JA, Boxer LA. Regulation of polymorphonuclear leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-activated protein kinase. Blood 2000; 95: 2407-12.
17. Wei Q, Adelstein RS. Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells. Mol Biol Cell 2000; 11: 3617-27.
18. Jacobelli J, Chmura SA, Buxton DB, Davis MM, Krummel MF. A single class II myosin modulates T cell motility and stopping, but not synapse formation. Nat Immunol 2004; 5: 531-8.
19. Maupin P, Phillips CL, Adelstein RS, Pollard TD. Differential localization of myosin-II isozymes in human cultured cells and blood cells. J Cell Sci 1994; 107: 3077-90.
20. Kawamoto S, Adelstein RS. Chicken nonmuscle myosin heavy chains: differential expression of two mRNAs and evidence for two different polypeptides. J Cell Biol 1991; 112: 915-24.
21. Fox JE. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-93.
22. Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001; 86: 198-213.
23. Grondin P, Plantavid M, Sultan C, Breton M, Mauco G, Chap H. Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem 1991; 266: 15705-9.
24. Jackson SP, Schoenwaelder SM, Yuan Y, Rabinowitz I, Salem HH, Mitchell CA. Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets. J Biol Chem 1994; 269: 27093-9.
25. Torti M, Bertoni A, Canobbio I, Sinigaglia F, Lapetina EG, Balduini C. Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FcgammaII receptor-mediated protein tyrosine phosphorylation. J Biol Chem 1999; 274: 13690-7.
26. Torti M, Ramaschi G, Sinigaglia F, Lapetina EG, Balduini C. Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation. Proc Natl Acad Sci USA 1993; 90: 7553-7.
27. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson EA, Cazenave J-P, Chap H, Gachet C. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR-1 activating peptide through the late activation of phosphatidylinositol 3-kinase. Blood 1999; 94: 4156-65.
28. Lova P, Campus F, Lombardi R, Cattaneo M, Sinigaglia F, Balduini C, Torti M. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the Gi-independent activation of platelet Rap1B by thrombin. J Biol Chem 2004; 279: 25299-306.
29. Hartwig J, Italiano J Jr. The birth of the platelet. J Thromb Haemost 2003; 1: 1580-6.
30. Godwin HA, Ginsburg AD. May-Hegglin anomaly: a defect of megakaryocyte fragmentation? Br J Haematol 1974; 26: 117-28.
31. Heynen MJ, Blockmans D, Verwilghen RL, Vermylen J. Congenital macrothrombocytopenia, leukocyte inclusions, deafness and proteinuria: functional and electron microscopy observations on platelet and megakaryocytes. Br J Haematol 1988; 70: 441-8.
32. Hamilton RW, Shalk BS, Ottie JN, Storch AE, Saleem A, White JG. Platelet function, ultrastructure, and survival in the May-Hegglin anomaly. Am J Clin Pathol 1980; 74: 663-8.
33. Deutsch S, Rideau A, Bochaton-Piallat ML, Merla G, Geinoz A, Gabbiani G, Schwede T, Matthes T, Antonarakis SE, Beris P. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 2003; 102: 529-34.
34. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998; 104: 355-60.
35. Lusher JM, Barnhart MI. Congenital disorders affecting platelets. Semin Thromb Haemost 1977; 4: 123-86.
36. Siess W. Molecular mechanims of platelet activation. Physiol Rev 1989; 69: 58-178.
37. Torti M, Tolnai-Festetics E, Bertoni A, Sinigaglia F, Balduini C. Agonist-induced actin polymerization is required for the irreversibility of platelet aggregation. Thromb Heamost 1996; 76: 444-9.
38. Nieswandt B, Bergmeier W, Eckly A, Schulte V, Ohlmann P, Cazenave JP, Zirngibl H, Offermanns S, Gachet C. Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. Blood 2001; 97: 3829-35.
39. Ohlmann P, Eckly A, Freund M, Cazenave JP, Offermanns S, Gachet C. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Gαq. Blood 2000; 96: 2134-9.
40. DiPumpo M, Noris P, Pecci A, Savoia A, Seri M, Ceresa IF, Balduini CL. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome. Haematologica 2002; 87: 943-7.
41. Ghiggeri GM, Caridi G, Magrini U, Sessa A, Savoia A, Seri M, Pecci A, Romagnoli R, Gangarossa S, Noris P, Sartore S, Necchi V, Ravazzolo R, Balduini CL. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) Am J Kidney Dis 2003; 41: 95-104.
42. Lalwani AK, Goldstein JA, Kelley MJ, Luxford W, Castelein CM, Mhatre AN. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000; 67: 1121-8.
43. Mhatre AN, Li J, Kim Y, Coling DE, Lalwani HK. Cloning and developmental expression of non muscle myosin IIA (Myh9) in the mammalian inner ear. J Neurosci Res 2004; 76: 296-305.